Aequus Pharmaceuticals (Aequus Pharmaceuticals) Net Interest Income : $-0.05 Mil (TTM As of Sep. 2023)

View and export this data going back to 2015. Start your Free Trial

What is Aequus Pharmaceuticals Net Interest Income?

Net interest income is the total interest income minus total interest expense. It represents the difference between interest and dividends earned on interestbearing assets and interest paid to depositors and other creditors. Aequus Pharmaceuticals's net interest income for the three months ended in Sep. 2023 was $-0.03 Mil. Its net interest income for the trailing twelve months (TTM) ended in Sep. 2023 was $-0.05 Mil.

Aequus Pharmaceuticals Net Interest Income Historical Data

The historical data trend for Aequus Pharmaceuticals's Net Interest Income can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Aequus Pharmaceuticals Net Interest Income Chart

Aequus Pharmaceuticals Annual Data

Trend

Dec13

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Net Interest Income

Get a 7-Day Free Trial

-0.31

-0.40

-0.35

-0.14

Aequus Pharmaceuticals Quarterly Data
	Jun18	Sep18	Dec18	Mar19	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Sep23
Net Interest Income	Get a 7-Day Free Trial															-0.09	-0.04	-0.01	-0.02	-0.03

Aequus Pharmaceuticals Net Interest Income Calculation

Net Interest Income for the trailing twelve months (TTM) ended in Sep. 2023 adds up the quarterly data reported by the company within the most recent 12 months, which was $-0.05 Mil.

Aequus Pharmaceuticals Net Interest Income Related Terms

Thank you for viewing the detailed overview of Aequus Pharmaceuticals's Net Interest Income provided by GuruFocus.com. Please click on the following links to see related term pages.

Aequus Pharmaceuticals (Aequus Pharmaceuticals) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Aequus Pharmaceuticals Inc (OTCPK:AQSZF) » Definitions » Net Interest Income

Comparable Companies

Traded in Other Exchanges

AEQ:Germany AQS:Canada

Address

200 Granville Street, Suite 2820, Vancouver, BC, CAN, V6C 1S4

Website

https://www.aequuspharma.ca

Aequus Pharmaceuticals Inc is a Canada-based specialty pharmaceutical company. The firm's operating segments are the Commercial platform and Development pipeline. It generates a majority of its revenue from the Commercial platform segment. The Company earns revenues from the sale of dry eye products and by providing promotional services to sell third-party-owned products, namely Tacrolimus IR and Vistitan.